Conversion to a sirolimus‐based regimen is associated with lower incidence of BK viremia in low‐risk kidney transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|1|66-72

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.1, 2015-02, pp. : 66-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 536-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 1, 2018-01 ,pp. : 245-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of a Weight‐based Rabbit Anti‐thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 748-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Withdrawal of tacrolimus stabilizes TGF‐β

By  

NEPHROLOGY, Vol. 20, Iss. 3, 2015-03 ,pp. : 168-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2726-2731

John Wiley & Sons Inc

Access to resources Recommend Favorite